HPS Pharmacies wish to advise that AstraZeneca Pty Ltd are currently experiencing an interruption to the supply of:
Suxamethonium Hydrochloride Injection BP
100mg in 2mL, 50 x 2mL
ARTG ID: 11988
This supply interruption is due to difficulties experienced in sourcing the active ingredient and may continue until the end of April 2015.
AstraZeneca supplies the only brand of suxamethonium registered in Australia, and health practitioners are requested to reserve remaining supplies for essential and emergency requirements only. Furthermore, AstraZeneca has retained a small emergency stock for distribution to facilities at most need, and HPS Pharmacies will manage its remaining stocks to maintain continuity of care where possible.
Please retain this notice in a prominent position, including in other related business units as a reminder for all staff members until supply returns to normal.
Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies, or AstraZeneca Customer Service on 1800 226 591.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.